Answers are grounded in this paper and cite their sources.
Background Refractory acute gout in elderly patients with multimorbidity is difficult to manage because standard anti-inflammatory therapies, including nonsteroidal anti-inflammatory drugs, colchicine, and glucocorticoids, may be ineffective or contraindicated. Interleukin-1β (IL-1β) inhibition represents a potential alternative for high-risk patients with limited treatment options. Methods We report the clinical course of a 69-year-old male with a 40-year history of refractory gout complicated by hypertension, type 2 diabetes mellitus, valvular heart disease, hepatic dysfunction, bilateral multiple renal cysts, and recent maxillofacial infection. The patient presented with severe polyarticular inflammation and markedly elevated high-sensitivity C-reactive protein (hs-CRP, 152.4 mg/L), with poor response to prior oral diclofenac. Because conventional anti-inflammatory therapies were unsuitable, a single 200 mg subcutaneous dose of the IL-1β inhibitor firsekibart was administered. Clinical symptoms, visual analogue scale (VAS) pain score, inflammatory markers, serum urate, organ function, recurrence, and adverse events were monitored during treatment and four months of follow-up. Results After firsekibart administration, pain and joint inflammation improved rapidly. The VAS score decreased from 7 at baseline to 2 by day 7, and hs-CRP normalized to 3.9 mg/L by day 6. During the four-month follow-up, the patient remained free of gout flares and reported no adverse events. Conclusion This case suggests that firsekibart may provide rapid and pronounced anti-inflammatory effects in elderly patients with refractory gout and complex multimorbidity, supporting the use of IL-1β inhibitors in high-risk populations with limited treatment alternatives. Further studies with larger samples and longer follow-up are needed to confirm its safety and effectiveness in high-risk real-world populations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: